Alpha-9 Theranostics

ActiveOn the Canada Radar · not ranked

Radiopharmaceuticals

Last roundSeries C · Oct 2024

Why Alpha-9 Theranostics is not ranked yet

The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. Alpha-9 Theranostics enters the ranking once its public data is sufficient for the AI to estimate it. Next Canada edition: 9 Oct 2026.

Funding history

Date	Round	Amount	Type	Investors
Oct 2024	Series C	USD 128-175M (reported range)	—	Andreessen Horowitz, Frazier, BVF

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Canada · all sectors	Radar	—	Edition 0 – beta · October 2026	9 Oct 2026

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Alpha-9 Theranostics as a PDF, on one of three angles only:

ValuationWhat is Alpha-9 Theranostics worth?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back Alpha-9 Theranostics whether or not it has agreed: your intention joins the pool on Alpha-9 Theranostics, passed to the local partner once it reaches critical mass. Declaring an intention does not mean this company is raising funds.

Back Alpha-9 Theranostics Or back biotech in Canada

Pool on Alpha-9 TheranosticsBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until a deal process opens. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Alpha-9 Theranostics?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in Canada

Full Canada ranking →

Borealis Biosciences#26Biotech › RNA therapies for kidney diseaseHundreds of M$Aspect Biosystems#33Biotech › bioprinted tissue therapiesHundreds of M$Abdera Therapeutics#35Biotech › antibody radiopharmaceuticalsHundreds of M$35Pharma#49Biotech › activin inhibitorsHundreds of M$

Investors in Alpha-9 Theranostics: Andreessen Horowitz · Frazier · BVF

Last updated: Oct 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.